{"abstract": "Carl C. Icahn may have some tricks up his sleeve to persuade Bristol-Myers Squibb to raise its $60-per-share offer for ImClone Systems, Forbes says.", "web_url": "https://dealbook.nytimes.com/2008/08/07/parsing-icahns-imclone-strategy/", "snippet": "", "lead_paragraph": "Carl C. Icahn may have some tricks up his sleeve to persuade Bristol-Myers Squibb to raise its $60-per-share offer for ImClone Systems, Forbes says.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Parsing Icahn\u2019s ImClone Strategy", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2008-08-07T11:45:05+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/06ae7bb8-b8df-53fa-a8d0-1c08ca8c495c", "word_count": 227, "uri": "nyt://article/06ae7bb8-b8df-53fa-a8d0-1c08ca8c495c"}